MDL 201112
MDL 201112 is a carbocyclic nucleoside. MDL 201112 can decrease TNF-α production and inhibit MHC class II Ia+ antigen expression. MDL 201112 can be used for the research of inflammation and immunology[1].
Product Specifications
CAS Number
142130-73-2
UNSPSC
12352005
Target
MHC; TNF Receptor
Related Pathways
Apoptosis; Immunology/Inflammation
Field of Research
Inflammation/Immunology
Smiles
NC1=NC=NC2=C1N=CN2[C@@H]3C[C@H](O)CC3
Molecular Formula
C10H13N5O
Molecular Weight
219.24
References & Citations
[1]Edwards CK 3rd, et al. Effect of the carbocyclic nucleoside analogue MDL 201,112 on inhibition of interferon-gamma-induced priming of Lewis (LEW/N) rat macrophages for enhanced respiratory burst and MHC class II Ia+ antigen expression. J Leukoc Biol. 1994 Aug;56 (2) :133-44.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
MHC II
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC880965-100 1x 100 µL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681227-100 1x 100 µL
Thyroglobulin (TGB04 + TGB05), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401840-100 1x 100 µL
Cytokeratin 1 (Suprabasal Keratinocyte Marker) (KRT1/1840), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details